Reuters - Health Report

Click to View in Browser

Tuesday, December 19, 2017

Prenatal and early childhood fructose tied to asthma in kids

(Reuters Health) - - Grade school kids may be more likely to develop asthma if they consumed lots of drinks sweetened with sugar and high fructose corn syrup or if their mothers drank these beverages often during pregnancy, a recent study suggests.

Court orders Trump administration to give immigrant teens abortion access

WASHINGTON (Reuters) - A U.S. District Court judge ruled on Monday that President Donald Trump's administration must allow access to abortion for two pregnant teenagers who are in the country illegally, escalating a high-profile legal fight.

Roche touts Swiss-led R&D unit after years in Genentech's shadow

ZURICH (Reuters) - Roche is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.

Dr. Reddy's resolves U.S. probe over child safety of drug packaging

(Reuters) - Dr. Reddy's Laboratories Ltd will pay $5 million to resolve U.S. claims that the Indian company sold prescription drugs in the United States in packaging that was not tested for child safety, according to court papers filed on Monday.

Exercise, pills, brain training show little hard evidence of slowing dementia

(Reuters Health) - - An extensive review of research on exercise, nutritional supplements, drugs and brain-training techniques concludes there is no definitive evidence that any of them protect against Alzheimer's disease or other types of dementia.

Preemies and underweight babies more likely to develop ADHD

(Reuters Health) - - Babies who are born too soon or arrive weighing too little are about three times more likely to develop attention deficit hyperactivity disorder (ADHD) than full-term, healthy-sized infants, a research review suggests.

Hikma wins right to market Roche drug copy in Middle East and North Africa

(Reuters) - Hikma Pharmaceuticals Plc has won exclusive rights to distribute and market its third biosimilar drug - a copy of Roche's blood cancer treatment Rituxanin - in the Middle East and North African markets, it said on Tuesday.

Aerie's glaucoma treatment gets early FDA approval

(Reuters) - Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its eyedrop, Rhopressa, as a treatment for glaucoma, two months ahead of the expected date.

Probiotics and xylitol don’t help sore throats

(Reuters Health) - - Two potential remedies for bacterial infections, probiotics and xylitol, didn’t ease sore throat symptoms in an experiment designed to see whether these options might be used to curb overuse of antibiotics.

Teen sexual identity, childhood trauma linked to suicidal behaviors

(Reuters Health) - - Both LGBQ sexual identity and traumatic experiences in childhood are linked to a heightened risk of suicidal thoughts and behaviors, U.S. researchers say.